Chromosomal Microarray Analysis in Children with Unexplained Developmental Delay/Intellectual Disability

Abstract

Chromosomal microarray (CMA) analysis for discovery of copy number variants (CNVs) is now recommended as a first-line diagnostic tool in patients with unexplained developmental delay/intellectual disability (DD/ID) and autism spectrum disorders. In this study, we present the results of CMA analysis in patients with DD/ID. Of 210 patients, pathogenic CNVs were detected in 26 (12%) and variants of uncertain clinical significance in 36 (17%) children. The diagnosis of well-recognized genetic syndromes was achieved in 12 patients. CMA analysis revealed pathogenic de novo CNVs, such as 11p13 duplication with new clinical features. Our results support the utility of CMA as a routine diagnostic test for unexplained DD/ID.

Keywords

chromosomal microarray analysis - developmental delay - intellectual disability - microdeletion/microduplication

• References

• 1 Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S. Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil 2011; 32 (02) 419-436
• 2 Kaufman L, Ayub M, Vincent JB. The genetic basis of non-syndromic intellectual disability: a review. J Neurodev Disord 2010; 2 (04) 182-209
• 3 Najmabadi H, Hu H, Garshasbi M. , et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011; 478 (7367): 57-63
• 4 Miller DT, Adam MP, Aradhya S. , et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86 (05) 749-764
• 5 Arican P, Cavusoglu D, Gencpinar P, Ozyilmaz B, Ozdemir TR, Dundar NO. A De Novo Xp11.23 duplication in a girl with a severe phenotype: expanding the clinical spectrum. J Pediatr Genet 2018; 7 (02) 74-77
• 6 Rosenfeld JA, Patel A. Chromosomal microarrays: understanding genetics of neurodevelopmental disorders and congenital anomalies. J Pediatr Genet 2017; 6 (01) 42-50
• 7 Ben Khelifa H, Soyah N, Labalme A. , et al. Genomic microarray in intellectual disability: the usefulness of existing systems in the interpretation of copy number variation. J Pediatr Genet 2017; 6 (02) 84-91
• 8 Ballif BC, Hornor SA, Sulpizio SG. , et al. Development of a high-density pericentromeric region BAC clone set for the detection and characterization of small supernumerary marker chromosomes by array CGH. Genet Med 2007; 9 (03) 150-162
• 9 Leroy C, Landais E, Briault S. , et al. The 2q37-deletion syndrome: an update of the clinical spectrum including overweight, brachydactyly and behavioural features in 14 new patients. Eur J Hum Genet 2013; 21 (06) 602-612
• 10 Lisi EC, Hamosh A, Doheny KF. , et al. 3q29 interstitial microduplication: a new syndrome in a three-generation family. Am J Med Genet A 2008; 146A [phone]
• 11 Fernández-Jaén A, Castellanos MC, Fernández-Perrone AL. , et al. Cerebral palsy, epilepsy, and severe intellectual disability in a patient with 3q29 microduplication syndrome. Am J Med Genet A 2014; 164A [phone]
• 12 Xu J, Gong NL, Bodi I, Aronow BJ, Backx PH, Molkentin JD. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J Biol Chem 2006; 281 (14) 9152-9162
• 13 Xu S, Han JC, Morales A, Menzie CM, Williams K, Fan YS. Characterization of 11p14-p12 deletion in WAGR syndrome by array CGH for identifying genes contributing to mental retardation and autism. Cytogenet Genome Res 2008; 122 (02) 181-187
• 14 Han JC, Thurm A, Golden Williams C. , et al. Association of brain-derived neurotrophic factor (BDNF) haploinsufficiency with lower adaptive behaviour and reduced cognitive functioning in WAGR/11p13 deletion syndrome. Cortex 2013; 49 (10) 2700-2710
• 15 Engels H, Schüler HM, Zink AM. , et al. A phenotype map for 14q32.3 terminal deletions. Am J Med Genet A 2012; 158A [phone]
• 16 Bundey S, Hardy C, Vickers S, Kilpatrick MW, Corbett JA. Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia. Dev Med Child Neurol 1994; 36 (08) 736-742
• 17 Burnside RD, Pasion R, Mikhail FM. , et al. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet 2011; 130 (04) 517-528
• 18 van Bon BW, Mefford HC, Menten B. , et al. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet 2009; 46 (08) 511-523
• 19 de Munnik SA, García-Miñaúr S, Hoischen A. , et al. A de novo non-sense mutation in ZBTB18 in a patient with features of the 1q43q44 microdeletion syndrome. Eur J Hum Genet 2014; 22 (06) 844-846
• 20 Weiss LA, Shen Y, Korn JM. , et al; Autism Consortium. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008; 358 (07) 667-675
• 21 Shinawi M, Liu P, Kang SH. , et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 2010; 47 (05) 332-341
• 22 Tassano E, Severino M, Rosina S. , et al. Interstitial de novo 18q22.3q23 deletion: clinical, neuroradiological and molecular characterization of a new case and review of the literature. Mol Cytogenet 2016; 9: 78
• 23 Portnoï MF. Microduplication 22q11.2: a new chromosomal syndrome. Eur J Med Genet 2009; 52 (2–3): 88-93
• 24 Yu S, Cox K, Friend K. , et al. Familial 22q11.2 duplication: a three-generation family with a 3-Mb duplication and a familial 1.5-Mb duplication. Clin Genet 2008; 73 (02) 160-164
• 25 Rainger JK, Bhatia S, Bengani H. , et al. Disruption of SATB2 or its long-range cis-regulation by SOX9 causes a syndromic form of Pierre Robin sequence. Hum Mol Genet 2014; 23 (10) 2569-2579
• 26 Fusco F, Pescatore A, Bal E. , et al. Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations. Hum Mutat 2008; 29 (05) 595-604